• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病的环境触发因素:研究进展与证据回顾。

Environmental triggers in IBD: a review of progress and evidence.

机构信息

Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Boston, Massachusetts 02114, USA.

University of Manitoba IBD Clinical and Research Centre, 804-F-175 McDermot Avenue, Winnipeg Manitoba R3E 3P4, Canada.

出版信息

Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):39-49. doi: 10.1038/nrgastro.2017.136. Epub 2017 Oct 11.

DOI:10.1038/nrgastro.2017.136
PMID:29018271
Abstract

A number of environmental factors have been associated with the development of IBD. Alteration of the gut microbiota, or dysbiosis, is closely linked to initiation or progression of IBD, but whether dysbiosis is a primary or secondary event is unclear. Nevertheless, early-life events such as birth, breastfeeding and exposure to antibiotics, as well as later childhood events, are considered potential risk factors for IBD. Air pollution, a consequence of the progressive contamination of the environment by countless compounds, is another factor associated with IBD, as particulate matter or other components can alter the host's mucosal defences and trigger immune responses. Hypoxia associated with high altitude is also a factor under investigation as a potential new trigger of IBD flares. A key issue is how to translate environmental factors into mechanisms of IBD, and systems biology is increasingly recognized as a strategic tool to unravel the molecular alterations leading to IBD. Environmental factors add a substantial level of complexity to the understanding of IBD pathogenesis but also promote the fundamental notion that complex diseases such as IBD require complex therapies that go well beyond the current single-agent treatment approach. This Review describes the current conceptualization, evidence, progress and direction surrounding the association of environmental factors with IBD.

摘要

许多环境因素与 IBD 的发展有关。肠道微生物群的改变,或称为菌群失调,与 IBD 的发生或进展密切相关,但菌群失调是原发性还是继发性事件尚不清楚。然而,生命早期的事件,如出生、母乳喂养和接触抗生素,以及后来的儿童时期的事件,被认为是 IBD 的潜在危险因素。空气污染是无数化合物对环境不断污染的结果,也是与 IBD 相关的另一个因素,因为颗粒物或其他成分可以改变宿主的黏膜防御并引发免疫反应。与高海拔相关的缺氧也是一个正在研究的潜在新的 IBD 发作触发因素。一个关键问题是如何将环境因素转化为 IBD 的发病机制,系统生物学越来越被认为是揭示导致 IBD 的分子改变的战略工具。环境因素增加了对 IBD 发病机制理解的复杂性,但也促进了这样一个基本概念,即像 IBD 这样的复杂疾病需要复杂的治疗方法,远远超出当前的单一药物治疗方法。本文综述了目前关于环境因素与 IBD 关联的概念化、证据、进展和方向。

相似文献

1
Environmental triggers in IBD: a review of progress and evidence.炎症性肠病的环境触发因素:研究进展与证据回顾。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):39-49. doi: 10.1038/nrgastro.2017.136. Epub 2017 Oct 11.
2
Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.炎症性肠病的环境风险因素:基于证据的文献综述。
World J Gastroenterol. 2016 Jul 21;22(27):6296-317. doi: 10.3748/wjg.v22.i27.6296.
3
Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.炎症性肠病和结直肠癌中的微生物群变化:结肠细胞反应的改变
World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121.
4
The Role of Environmental Factors in the Pathogenesis of Inflammatory Bowel Diseases: A Review.环境因素在炎症性肠病发病机制中的作用:综述。
JAMA Pediatr. 2017 Oct 1;171(10):999-1005. doi: 10.1001/jamapediatrics.2017.2571.
5
Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy.炎症性肠病:发病机制和治疗的既定和不断发展的考虑因素。
J Dig Dis. 2010 Oct;11(5):266-76. doi: 10.1111/j.1751-2980.2010.00449.x.
6
Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD?非甾体抗炎药、抗生素、感染或压力会引发炎症性肠病发作吗?
Am J Gastroenterol. 2009 May;104(5):1298-313; quiz 1314. doi: 10.1038/ajg.2009.15. Epub 2009 Mar 31.
7
Westernized Diet is the Most Ubiquitous Environmental Factor in Inflammatory Bowel Disease.西式饮食是炎症性肠病中最普遍的环境因素。
Perm J. 2019;23:18-107. doi: 10.7812/TPP/18-107.
8
High Altitude Journeys, Flights and Hypoxia: Any Role for Disease Flares in IBD Patients?高原旅行、飞行与缺氧:炎症性肠病患者疾病发作的相关作用?
Dig Dis. 2016;34(1-2):78-83. doi: 10.1159/000442932. Epub 2016 Mar 16.
9
The gut microbiota and inflammatory bowel disease.肠道微生物群与炎症性肠病
Semin Immunopathol. 2015 Jan;37(1):47-55. doi: 10.1007/s00281-014-0454-4. Epub 2014 Nov 25.
10
Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.炎症性肠病中噬菌体、微生物与宿主之间的病理和治疗相互作用。
World J Gastroenterol. 2015 Oct 28;21(40):11321-30. doi: 10.3748/wjg.v21.i40.11321.

引用本文的文献

1
Low-Density Lipoprotein and High-Density Lipoprotein as Biomarkers for Inflammatory Bowel Disease Activity Assessment.低密度脂蛋白和高密度脂蛋白作为炎症性肠病活动度评估的生物标志物
Int J Gen Med. 2025 Sep 4;18:5115-5125. doi: 10.2147/IJGM.S529428. eCollection 2025.
2
Intestinal taurine acts as a novel immunometabolic modulator of IBD by degrading redundant mitochondrial RNA.肠道牛磺酸通过降解多余的线粒体RNA,作为炎症性肠病的一种新型免疫代谢调节剂。
Cell Mol Immunol. 2025 Sep 8. doi: 10.1038/s41423-025-01344-0.
3
Air Pollution and Disrupted Microbiomes: Tracing the Impact on Human Health.

本文引用的文献

1
Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.早年的城乡居住情况与炎症性肠病风险相关:一项基于人群的起始队列和出生队列研究。
Am J Gastroenterol. 2017 Sep;112(9):1412-1422. doi: 10.1038/ajg.2017.208. Epub 2017 Jul 25.
2
Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.系统评价与荟萃分析:粪便微生物群移植诱导活动性溃疡性结肠炎缓解的研究
Aliment Pharmacol Ther. 2017 Aug;46(3):213-224. doi: 10.1111/apt.14173. Epub 2017 Jun 14.
3
空气污染与微生物群落紊乱:追踪其对人类健康的影响。
Cureus. 2025 Aug 2;17(8):e89267. doi: 10.7759/cureus.89267. eCollection 2025 Aug.
4
Geographic distribution of inflammatory bowel disease in the UK: A spatially explicit survey.英国炎症性肠病的地理分布:一项空间明确的调查。
PLoS One. 2025 Aug 28;20(8):e0329317. doi: 10.1371/journal.pone.0329317. eCollection 2025.
5
Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in a Murine Model of Colitis.大麻二酚增强奥沙拉嗪和环孢素在小鼠结肠炎模型中的治疗效果。
Int J Mol Sci. 2025 Aug 16;26(16):7913. doi: 10.3390/ijms26167913.
6
The Role of Gut Microbiota in Gastrointestinal Immune Homeostasis and Inflammation: Implications for Inflammatory Bowel Disease.肠道微生物群在胃肠道免疫稳态和炎症中的作用:对炎症性肠病的影响
Biomedicines. 2025 Jul 24;13(8):1807. doi: 10.3390/biomedicines13081807.
7
Advances in oral treatment of inflammatory bowel disease using protein-based nanoparticle drug delivery systems.基于蛋白质的纳米颗粒药物递送系统在炎症性肠病口服治疗中的进展。
Drug Deliv. 2025 Dec;32(1):2544689. doi: 10.1080/10717544.2025.2544689. Epub 2025 Aug 11.
8
Association of Recreational Physical Activity with Gut Microbiota Diversity and Composition, and Symptom Burden in Crohn's Disease: A Cross-Sectional Study.休闲体育活动与克罗恩病患者肠道微生物群多样性、组成及症状负担的关联:一项横断面研究
J Inflamm Res. 2025 Jul 31;18:10295-10310. doi: 10.2147/JIR.S528820. eCollection 2025.
9
Effects of choline metabolite-trimethylamine N-oxide on immunometabolism in inflammatory bowel disease.胆碱代谢产物——氧化三甲胺对炎症性肠病免疫代谢的影响。
Front Immunol. 2025 Jul 17;16:1591151. doi: 10.3389/fimmu.2025.1591151. eCollection 2025.
10
Gemifloxacin ameliorates acetic acid-induced ulcerative colitis via modulation of inflammatory, oxidative, and adhesive biomarkers and histopathological changes in rats.吉米沙星通过调节大鼠炎症、氧化和黏附生物标志物以及组织病理学变化来改善乙酸诱导的溃疡性结肠炎。
J Mol Histol. 2025 Jul 31;56(4):250. doi: 10.1007/s10735-025-10527-y.
Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China.
炎症性肠病的全球化:从英国和中国炎症性肠病的演变看问题。
Lancet Gastroenterol Hepatol. 2016 Dec;1(4):307-316. doi: 10.1016/S2468-1253(16)30077-2. Epub 2016 Nov 10.
4
Modifiable Environmental Factors in Inflammatory Bowel Disease.炎症性肠病中的可改变环境因素
Curr Gastroenterol Rep. 2017 May;19(5):21. doi: 10.1007/s11894-017-0562-0.
5
Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation.膳食乳化剂可直接改变人体微生物群组成并在体外增强肠道炎症,从而影响基因表达。
Gut. 2017 Aug;66(8):1414-1427. doi: 10.1136/gutjnl-2016-313099. Epub 2017 Mar 21.
6
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.多供体强化粪菌移植治疗活动期溃疡性结肠炎:一项随机安慰剂对照试验。
Lancet. 2017 Mar 25;389(10075):1218-1228. doi: 10.1016/S0140-6736(17)30182-4. Epub 2017 Feb 15.
7
The Human Intestinal Microbiome in Health and Disease.健康与疾病中的人类肠道微生物群
N Engl J Med. 2016 Dec 15;375(24):2369-2379. doi: 10.1056/NEJMra1600266.
8
Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.锌缺乏与炎症性肠病患者不良临床结局相关。
Inflamm Bowel Dis. 2017 Jan;23(1):152-157. doi: 10.1097/MIB.0000000000000989.
9
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.了解和预防炎症性肠病的全球增长。
Gastroenterology. 2017 Feb;152(2):313-321.e2. doi: 10.1053/j.gastro.2016.10.020. Epub 2016 Oct 25.
10
Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.饮食作为炎症性肠病的诱因或疗法。
Gastroenterology. 2017 Feb;152(2):398-414.e6. doi: 10.1053/j.gastro.2016.10.019. Epub 2016 Oct 25.